Piedmont Healthcare Inc. — Atlanta, Georgia

Public research footprint of Piedmont Healthcare Inc., compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

NSCLC (Advanced Non-small Cell Lung Cancer) · Heart Failure · Idiopathic Pulmonary Fibrosis · Interstitial Lung Disease With Progressive Fibrotic Phenotype in…

Recently updated registry entries

NCT05677100 — Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure (Recruiting)
NCT06506942 — The TRICURE EFS Study (Recruiting)
NCT06881784 — Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Piedmont Healthcare Inc.?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.